Q1 2026 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2026-05-15 · accession 0001172661-26-002081
$2.09B
Reported value
90
Positions
2026-03-31
Period end
The Brief · Integral Health Asset Management, LLC · Q1 2026
AI · grounded in 13F
Integral Health Asset Management, LLC closed its position in MDT for a reduction of $64.8M. The fund established a new position in AZN valued at $49.3M and exited holdings in AZNN and TEVA for $32.2M and $31.2M respectively. Additionally, the manager increased its stake in ROIV by 135.3% and RVMD by 129.2%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $245.3M | 11.7% | 1,500,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $145.9M | 6.98% | 1,500,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $105.5M | 5.04% | 1,600,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $72.9M | 3.49% | 750,000 | PUT | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $65.9M | 3.15% | 1,000,000 | CALL | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $65.7M | 3.14% | 85,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $64.4M | 3.08% | 1,600,000 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $57.1M | 2.73% | 270,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $55.4M | 2.65% | 2,000,000 | Common | SOLE |
| 10950A106 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $53.3M | 2.55% | 1,250,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $52.2M | 2.50% | 600,000 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $51.1M | 2.45% | 425,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $50.4M | 2.41% | 1,600,000 | Common | SOLE |
| G0593M107 | AZN | ASTRAZENECA PLC | $49.3M | 2.36% | 250,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $48.6M | 2.33% | 500,000 | CALL | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $45.4M | 2.17% | 2,575,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $38.2M | 1.83% | 250,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $34.5M | 1.65% | 550,000 | Common | SOLE |
| 53228F101 | LFST | LIFESTANCE HEALTH GROUP INC | $27.4M | 1.31% | 4,300,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $26.3M | 1.26% | 115,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $24.6M | 1.18% | 500,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC FORMERLY | $22.0M | 1.05% | 75,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $21.3M | 1.02% | 650,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $20.4M | 0.98% | 275,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $20.3M | 0.97% | 750,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $19.8M | 0.95% | 150,000 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $18.8M | 0.90% | 175,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $18.8M | 0.90% | 300,000 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $17.9M | 0.85% | 40,000 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $17.7M | 0.85% | 1,400,000 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $17.6M | 0.84% | 800,000 | Common | SOLE |
| 358029106 | FMS | FRESENIUS MEDICAL CARE AG | $17.5M | 0.84% | 775,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $16.1M | 0.77% | 35,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $14.7M | 0.70% | 900,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $14.0M | 0.67% | 200,000 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $13.9M | 0.67% | 100,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $13.8M | 0.66% | 15,000 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $13.6M | 0.65% | 170,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $13.5M | 0.65% | 500,000 | CALL | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $13.5M | 0.64% | 350,000 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $13.2M | 0.63% | 550,000 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $13.1M | 0.63% | 25,000 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $12.9M | 0.62% | 40,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $12.6M | 0.60% | 150,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $12.6M | 0.60% | 1,500,000 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $11.8M | 0.56% | 60,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $11.6M | 0.56% | 200,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $11.3M | 0.54% | 700,000 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $11.2M | 0.54% | 500,000 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $11.0M | 0.53% | 60,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $11.0M | 0.53% | 175,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $10.9M | 0.52% | 325,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $10.9M | 0.52% | 170,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $10.8M | 0.52% | 700,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $10.8M | 0.52% | 150,000 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $10.7M | 0.51% | 150,000 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $9.8M | 0.47% | 20,000 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $9.5M | 0.46% | 150,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $9.5M | 0.45% | 125,000 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $9.4M | 0.45% | 450,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $9.4M | 0.45% | 125,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $9.2M | 0.44% | 3,200,000 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $9.1M | 0.44% | 80,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $9.1M | 0.44% | 1,750,000 | Common | SOLE |
| 29415F104 | NVST | ENVISTA HOLDINGS CORPORATION | $8.9M | 0.42% | 350,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $8.5M | 0.40% | 1,000,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $8.2M | 0.39% | 350,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $8.1M | 0.39% | 250,000 | Common | SOLE |
| 24477V105 | DFTX | DEFINIUM THERAPEUTICS INC | $7.6M | 0.36% | 400,000 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $7.1M | 0.34% | 300,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $6.1M | 0.29% | 2,000,000 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $6.1M | 0.29% | 200,000 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $6.0M | 0.29% | 35,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC. | $5.9M | 0.28% | 35,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $5.3M | 0.25% | 50,000 | Common | SOLE |
| 30054Y107 | EVMN | EVOMMUNE INC | $5.2M | 0.25% | 225,000 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY IN | $4.7M | 0.22% | 200,000 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $4.5M | 0.22% | 50,000 | Common | SOLE |
| 34962G208 | FBRX | FORTE BIOSCIENCES INC | $3.9M | 0.19% | 150,000 | Common | SOLE |
| 50180M108 | LBRX | LB PHARMACEUTICALS INC | $3.7M | 0.18% | 150,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $3.3M | 0.16% | 600,000 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $3.1M | 0.15% | 450,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $3.0M | 0.14% | 100,000 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $3.0M | 0.14% | 100,000 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $2.7M | 0.13% | 167,000 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $2.3M | 0.11% | 1,350,000 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $2.2M | 0.11% | 150,000 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $2.2M | 0.11% | 400,000 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $2.0M | 0.10% | 50,000 | Common | SOLE |
| 90466Y202 | UNCY | UNICYCIVE THERAPEUTICS INC | $1.5M | 0.07% | 225,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.